Fairleigh Dickinson University

Fairleigh Dickinson University, doing business as Wroxton College, is a private non-profit educational institution based in Teaneck, New Jersey, that serves the federal government primarily as a grant recipient (95% of recent awards) and occasionally as a contract prime, delivering STEM education, behavioral health workforce training, and applied research across life sciences and engineering disciplines. The university operates without set-aside designations and competes full-and-open across civilian federal agencies.

FDU's federal footprint spans thirteen active prime grants totaling approximately $4.5 million, anchored by workforce-development and biomedical research initiatives. Representative grant work includes a $560,491 award from the National Institute of Neurological Disorders and Stroke (CFDA 93.279) for phenotyping central sensitization in bladder pain syndrome using machine learning and secondary data analysis, running through July 2029; a $400,000 collaborative award from the National Science Foundation Technology, Innovation, and Partnerships program (CFDA 47.084) in partnership with the University of Minnesota Duluth to build research capacity and industry partnerships for biotechnology innovation through September 2027; a $199,844 NSF Engineering Research Initiation award (CFDA 47.041) to investigate mechanical stimuli and plant growth mechanisms relevant to crop resilience through May 2028; and a $691,111 Department of Education School Safety grant (CFDA 84.184) for mental health and student safety programming through December 2025. The university also holds grant awards from the Health Resources and Services Administration for behavioral health workforce development (including a $600,000 annual commitment for master's-level training in social work, psychiatric nursing, and school psychology), the National Science Foundation for STEM education and retention initiatives, and the National Institute on Drug Abuse for substance-use intervention research.

On the contract side, FDU holds a single-award Basic Ordering Agreement with the Department of the Navy's Bureau of Medicine and Surgery (BOA N0018924GZ026, established September 16, 2024, running through September 15, 2034) under which five firm fixed-price delivery orders for tuition and fees totaling $113,122 have been awarded since the BOA's inception. Representative task orders include a $27,527 delivery order issued January 28, 2026 for Naval personnel educational services, a $26,043 delivery order dated August 1, 2025, and a $21,486 award from January 2, 2025. Performance on all Navy contracts occurs at FDU's Teaneck campus.

Customer concentration reflects strong alignment with health workforce and research agencies. The Department of Health and Human Services Health Resources and Services Administration leads by award count (23 awards across Bureau of Health Professionals and base HRSA programs), while the Department of the Navy anchors dollar value through the education BOA (5 awards, $113,122 combined potential value) and Naval Air Systems Command provides supplemental volume (9 awards, $51,000 combined potential value). The National Science Foundation, National Institutes of Health, and Department of Veterans Affairs round out the active customer set. Total combined potential value across the federal portfolio is $775,000, with obligated dollars at $61.5 million—a ratio reflecting significant delivery on awarded work rather than forward commitments.

Activity has held steady at five to six awards annually over the past three years, with six awards reaching completion within the next twenty-four months, representing moderate recompete exposure. The university acts as sub-recipient on four grant sub-awards under primes including the University of Massachusetts Boston, Research Foundation of the State University of New York, University of Kentucky, and Rutgers University, with roles spanning research implementation and training activities including coaching programs and neuroscientific data analysis.

FDU's capability portfolio centers on federal workforce development in behavioral health (social work, psychiatric nursing, school psychology, community health worker training for opioid-affected families), STEM education and retention (particularly for Hispanic-serving institution populations), biomedical and pharmaceutical research (separation science, nanocoatings for anti-infection applications, central sensitization phenotyping), and mental health programming in K–12 settings. The university operates with four full-time equivalent research administration staff and has recently invested in expanding sponsored-project infrastructure to scale capacity alongside growing grant submissions and award volume.